Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization

NCT07512960 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

614

Enrollment

OTHER

Sponsor class

Conditions

CLTI Defined as Rutherford Category 4 or 5

Interventions

DRUG: Clopidogrel 75 mg/day
OTHER: Placebo Clopidogrel

Sponsor

Fondation Hôpital Saint-Joseph